M
MIRA Pharmaceuticals, Inc. (MIRA)
NCM – Real vaqt narxi. Valyuta: USD
1.02
+0.03 (3.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.00
-0.02 (-1.96%)
Bozor oldidan: May 13, 2026, 8:47 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.02
+0.03 (3.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.00
-0.02 (-1.96%)
Bozor oldidan: May 13, 2026, 8:47 AM EDT
MIRA Pharmaceuticals, Inc. ikkita nevrologik va neyropsixiatrik kasalliklarni davolashga qaratilgan ikkita nevrologiya dasturi bilan preklinik bosqichdagi farmatsevtika ishlab chiqaruvchi kompaniya sifatida faoliyat yuritadi. Kompaniya Ketamir-2 uchun AQSh, Kanada va Meksikada eksklyuziv huquqlarga ega bo'lib, bu keyingi avlod og'iz orqali yuboriladigan NMDA retseptorlari modulyatori bo'lib, u 1-bosqich klinik sinovlarini yakunlagan. Shuningdek, u og'iz orqali yuboriladigan farmatsevtika marixuanasi MIRA-55ni taklif etadi, bu tashvish va kognitiv pasayishdan aziyat chekayotgan kattalar bemorlarni davolash uchun tekshirilmoqda, ko'pincha demensiyaning dastlabki bosqichlari bilan bog'liq; va SKNY-1, semirish va nikotin ta'siriga bog'liqlikni davolash uchun preklinik bosqichda. Kompaniya ilgari MIRA1a Therapeutics, Inc. nomi bilan tanilgan. MIRA Pharmaceuticals, Inc. 2020 yilda tashkil etilgan va Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Itzchak Angel Ph.D. | Chief Scientific Advisor |
| Mr. Alan Weichselbaum CPA, M.B.A. | CFO & Treasurer |
| Mr. Erez Aminov | CEO & Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-31 | 10-K | form10-k.htm |
| 2026-03-23 | 8-K | form8-k.htm |
| 2026-03-03 | 8-K | form8-k.htm |
| 2026-02-02 | 8-K | form8-k.htm |
| 2025-12-22 | 8-K | form8-k.htm |
| 2025-12-05 | 8-K | form8-k.htm |
| 2025-11-13 | 10-Q | form10-q.htm |
| 2025-10-23 | 8-K | form8-k.htm |
| 2025-10-16 | 8-K | form8-k.htm |
| 2025-10-15 | 8-K | form8-k.htm |